Latest Articles

Publication Date
All News Scientific
AI model detects endometrial cancer at almost 100 per cent accuracy - NT News

AI model detects endometrial cancer at almost 100 per cent accuracy NT News

Published: March 19, 2025, 3:45 p.m.
Read Full Article
Canada Approves KEYTRUDA For Advanced Endometrial Cancer - Evrim Ağacı

Canada Approves KEYTRUDA For Advanced Endometrial Cancer Evrim Ağacı

Published: March 19, 2025, 2:55 p.m.
Read Full Article
Health Canada Approves KEYTRUDA® for the Treatment of Adult Patients with Primary Advanced or Recurrent Endometrial Carcinoma, in Combination with Carboplatin and Paclitaxel and then Continued as Monotherapy - Weekly Voice

Health Canada Approves KEYTRUDA® for the Treatment of Adult Patients with Primary Advanced or Recurrent Endometrial Carcinoma, in Combination with Carboplatin and Paclitaxel and then Continued as Monotherapy Weekly Voice

Published: March 19, 2025, 11:20 a.m.
Read Full Article
Health Canada Approves KEYTRUDA® for the Treatment of Adult Patients with Primary Advanced or Recurrent Endometrial Carcinoma, in Combination with Carboplatin and Paclitaxel and then Continued as Monotherapy - Yahoo Canada Finance

Health Canada Approves KEYTRUDA® for the Treatment of Adult Patients with Primary Advanced or Recurrent Endometrial Carcinoma, in Combination with Carboplatin and Paclitaxel and then Continued as Monotherapy Yahoo Canada …

Published: March 19, 2025, 11 a.m.
Read Full Article
Health Canada Approves KEYTRUDA® for the Treatment of Adult Patients with Primary Advanced or Recurrent Endometrial Carcinoma, in Combination with Carboplatin and Paclitaxel and then Continued as Monotherapy - Yahoo Finance

Health Canada Approves KEYTRUDA® for the Treatment of Adult Patients with Primary Advanced or Recurrent Endometrial Carcinoma, in Combination with Carboplatin and Paclitaxel and then Continued as Monotherapy Yahoo Finance

Published: March 19, 2025, 11 a.m.
Read Full Article
Investigational ADC Shows Promise in Advanced Endometrial Cancer - MSN

Investigational ADC Shows Promise in Advanced Endometrial Cancer MSN

Published: March 19, 2025, 1:18 a.m.
Read Full Article
Analysis of risk factors for recurrence after laparoscopic myomectomy: A retrospective study.

At present, there is unclear on the risk factors of recurrence after myomectomy. In this study, we hope to provide reference for the choice of treatment for patients with uterine …

Published: March 19, 2025, 12:17 a.m.
Read Full Article
Investigational ADC Shows Promise in Advanced Endometrial Cancer - Medpage Today

Investigational ADC Shows Promise in Advanced Endometrial Cancer Medpage Today

Published: March 18, 2025, 8:07 p.m.
Read Full Article
The Importance of Spotting Endometrial Cancer - Curetoday.com

The Importance of Spotting Endometrial Cancer Curetoday.com

Published: March 18, 2025, 3:24 p.m.
Read Full Article
Adding Olaparib (Lynparza) to Durvalumab (Imfinzi) Shows Benefit in Endometrial Cancer Subgroups - OBR Oncology

Adding Olaparib (Lynparza) to Durvalumab (Imfinzi) Shows Benefit in Endometrial Cancer Subgroups OBR Oncology

Published: March 18, 2025, 10:24 a.m.
Read Full Article
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!